Auteur G. J. DORE

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study

M. ALAVI ; J. GREBELY ; M. MICALLEF ; A. J. DUNLOP ; A. C. BALCOMB ; C. A. DAY ; C. TRELOAR ; N. BATH ; P. S. HABER ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique

BACKGROUND: Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic [...]

Plus d'info

Ajouter à la sélection

Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs [Commentary]

S. LARNEY ; J. GREBELY ; M. HICKMAN ; D. DE ANGELIS ; G. J. DORE ; L. DEGENHARDT | 2015
Dans International Journal of Drug Policy (Vol.26, n°10, October 2015) Article : Périodique

There is considerable interest in determining the impact that increased uptake of treatment for hepatitis C virus (HCV) infection will have on the burden of HCV among people who inject drugs (PWID). An understanding of the size of the population[...]

Plus d'info

Ajouter à la sélection

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

J. GREBELY ; G. J. DORE ; S. MORIN ; J. K. ROCKSTROH ; M. B. KLEIN | 2017
Dans Journal of the International AIDS Society (Vol.20, n°22146, August 2017) Article : Périodique

INTRODUCTION: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverag[...]

Plus d'info

Ajouter à la sélection

Lien externe

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]

Plus d'info

Ajouter à la sélection

Lien externe

Estimating the cost-effectiveness of needle-syringe programs in Australia

J. A. KWON ; J. ANDERSON ; C. C. KERR ; H. H. THEIN ; L. ZHANG ; J. IVERSEN ; G. J. DORE ; J. M. KALDOR ; M. G. LAW ; L. MAHER ; D. P. WILSON | 2012
Dans AIDS (Vol.26, n°17, November 2012) Article : Périodique

OBJECTIVE: To evaluate the impact and cost-effectiveness of needle-syringe programs (NSPs) with respect to HIV and hepatitis C virus (HCV) infections among Australian injecting drug users (IDUs). DESIGN/METHODS: A health economic analysis was [...]

Plus d'info

Ajouter à la sélection

Estimating the number of people who inject drugs in Australia

S. LARNEY ; M. HICKMAN ; R. GUY ; J. GREBELY ; G. J. DORE ; R. T. GRAY ; C. A. DAY ; J. KIMBER ; L. DEGENHARDT | 2017
Dans BMC Public Health (Vol.17, n°757, 2017) Article : Périodique

Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug [...]

Plus d'info

Ajouter à la sélection

Lien externe

International Journal of Drug Policy, Vol.26, n°10 - October 2015 - Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs

J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015
Bulletin : Périodique

Plus d'info

Ajouter à la sélection

Lien externe

Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs [Editorial]

J. GREBELY ; P. BRUGGMANN ; C. TRELOAR ; J. BYRNE ; T. RHODES ; G. J. DORE | 2015
Dans International Journal of Drug Policy (Vol.26, n°10, October 2015) Article : Périodique

Plus d'info

Ajouter à la sélection

Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique

BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]

Plus d'info

Ajouter à la sélection

Lien externe

Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT | 2019
Dans Addiction (Vol.114, n°1, January 2019) Article : Périodique

BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]

Plus d'info

Ajouter à la sélection

Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction

HALLINAN R. ; A. BYRNE ; G. J. DORE | 2007
Dans Drug and Alcohol Review (Vol.26 n°4, 2007) Article : Périodique

ENGLISH : While harm reduction advocates, policy makers and practitioners have a right to be proud of the impact of interventions such as needle and syringe programmes on HIV risk, we can be less sanguine about the ongoing high levels of HCV t[...]

Plus d'info

Ajouter à la sélection

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting : retrospective cohort study

I. VAN BEEK ; R. DWYER ; G. J. DORE ; K. LUO ; J. M. KALDOR | 1998
Périodique

FRANÇAIS : La cohorte étudiée a été recrutée parmi les patients d'un centre de prévention et traitement du VIH/Sida et autres maladies infectieuses à Sydney, qui accueille des usagers de drogues par voie injectable et des prostitués depuis 1987[...]

Plus d'info

Ajouter à la sélection

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : Périodique

Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]

Plus d'info

Ajouter à la sélection

Lien externe

Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review

S. BAJIS ; G. J. DORE ; B. HAJARIZADEH ; E. B. CUNNINGHAM ; L. MAHER ; J. GREBELY | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Background: The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to[...]

Plus d'info

Ajouter à la sélection

Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugs

J. GREBELY ; P. BRUGGMANN ; M. BACKMUND ; G. J. DORE | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique

The majority of hepatitis C virus (HCV) occurs among people who inject drugs (PWID), and the burden of HCV-related liver disease is still increasing. HCV treatment is safe and effective among PWID, and international guidelines encourage HCV trea[...]

Plus d'info

Ajouter à la sélection

Lien externe